Chancellor Financial Group WB’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Buy
+4,500
New +$193K 0.13% 136
2026
Q1
Sell
-4,414
Closed -$225K 147
2025
Q4
$225K Buy
+4,414
New +$226K 0.15% 121

Other funds holding NVO

Chancellor Financial Group WB's NVO Position: Q2 2026 in Review

Chancellor Financial Group WB opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,500 shares worth $216K. The stake represents 0.13% of the portfolio and ranks #136 among its holdings. This is a return to the name: Chancellor Financial Group WB previously reported a position in NVO as recently as Q4 2025.

Chancellor Financial Group WB first reported a position in NVO in Q4 2025 and has held it in 2 quarters since. The position peaked at $225K in Q4 2025. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Chancellor Financial Group WB held 4,500 shares of Novo Nordisk worth $216K as of Q2 2026.
  • Novo Nordisk was a new Chancellor Financial Group WB position in Q2 2026.
  • Novo Nordisk made up 0.13% of Chancellor Financial Group WB's portfolio in Q2 2026, its #136 holding.
  • Chancellor Financial Group WB first reported a position in Novo Nordisk in Q4 2025 and has held it in 2 quarters since.
  • Chancellor Financial Group WB's Novo Nordisk position peaked at $225K in Q4 2025.
  • 1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Chancellor Financial Group WB's 13F filing for Q2 2026, filed 10 Aug 2026.